Check-Cap Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

Here's Why We're Not Too Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

May 19

We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth

Feb 03

We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely

Oct 21

Check-Cap (NASDAQ:CHEK) Is In A Good Position To Deliver On Growth Plans

Jul 01

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Jan 02

Check Cap +1.5% on listing extension from NASDAQ

Dec 30

Check-Cap EPS misses by $0.01

Nov 18

CEO

Check-Cap heeft geen CEO, of we hebben geen gegevens over hen.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yoav Kimchy	Founder	less than a year	US$389.08k	0.062% $ 2.9k
Daniel Kokiw	Independent Director	less than a year	geen gegevens	geen gegevens
Michael Hutton	Independent Director	less than a year	geen gegevens	geen gegevens
David Lontini	Independent Director	less than a year	geen gegevens	geen gegevens
Carlos Cheung	Director	less than a year	geen gegevens	geen gegevens

0.8yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CHEK wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.

Check-Cap Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

High number of new and inexperienced directors

Check-Cap Ltd. Announces Executive Changes

Check-Cap Ltd. Announces CFO Changes

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Insufficient new directors

Recent updates

New minor risk - Share price stability

New major risk - Market cap size

High number of new and inexperienced directors

Check-Cap Ltd. announced delayed 20-F filing

New major risk - Revenue and earnings growth

New minor risk - Share price stability

Nobul AI Corp entered into a definitive Business Combination Agreement to acquire Check-Cap Ltd. (NasdaqCM:CHEK).

Check-Cap Ltd. Announces Executive Changes

Check-Cap Ltd. Announces CFO Changes

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Check-Cap Ltd. Announces Resignation of William Vozzolo as Member of the Board of Directors and Independent Member of the Audit Committee

Symetryx Corporation Recommends Shareholders to Vote Against the Keystone Dental Merger and For its Board Nominees

Symetryx Corporation Discloses its Views on Check-Cap

New major risk - Revenue and earnings growth

SBT Holdings Inc. entered into a definitive Business Combination Agreement to acquire Check-Cap Ltd. (NasdaqCM:CHEK) in a reverse merger transaction.

Check-Cap Ltd. Reports Impairment of Fixed Assets for the Second Quarter Ended June 30, 2023

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Here's Why We're Watching Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

Insufficient new directors

Check-Cap Ltd., Annual General Meeting, Dec 22, 2022

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

Check-Cap Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement

Here's Why We're Not Too Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Situation

Check-Cap Ltd. Announces the Initiation of its U.S. Pivotal Trial of C-Scana at Mayo Clinic in Rochester Minnesota

Price target decreased to US$3.00

Insufficient new directors

Check-Cap Ltd. Receives Approval from the U.S. Food and Drug Administration for Its Amended Investigational Device Exemption Application

We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

Check-Cap Ltd. Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for Its Colorectal Screening Test, C-Scan

We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely

Check-Cap (NASDAQ:CHEK) Is In A Good Position To Deliver On Growth Plans

No longer forecast to breakeven

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

New 90-day high: US$2.33

New 90-day high: US$1.85

We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate

New 90-day high: US$0.43

Check Cap +1.5% on listing extension from NASDAQ

New 90-day high: US$0.41

Check-Cap EPS misses by $0.01

New 90-day low: US$0.31

New 90-day low: US$0.34

New 90-day low - US$0.39

New 90-day high - US$0.80

CEO

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd